Expression of Programmed Death 1 Ligand 1 on Periodontal Tissue Cells As a Possible Protective Feedback Mechanism Against Periodontal Tissue Destruction

Overview

Journal Mol Med Rep

Specialty Molecular Biology

Date 2016 Feb 6

PMID 26847035

Citations 23

Authors

Jiehua Zhang

Chieh-Mei Wang

Ping Zhang

Xiaoqian Wang

Jiao Chen

Jun Yang

Wanlu Lu

Wenjie Zhou

Wenwen Yuan

Yun Feng

Affiliations

Soon will be listed here.

Abstract

Programmed death 1 ligand 1 (PD‑L1) is a negative co‑stimulatory molecule in immune responses. Previous reports have indicated that inflammatory cytokines can upregulate the expression of PD‑L1 in tumor cells, which in turn suppresses host immune responses. Periodontitis is characterized by persistent inflammation of the periodontium, which is initiated by infection with oral bacteria and results in damage to cells and the matrices of the periodontal connective tissues. In the present study, the expression and function of PD‑L1 in periodontal tissue destruction were examined. Periodontal ligament cells (PDLCs) were stimulated by inflammatory cytokines and periodontal pathogens. The expression and function of PD‑L1 on the surface of PDLCs was investigated using flow cytometry in vitro. Periodontal disease was induced by the injection of Porphyromonas gingivalis in mouse models. The expression levels of PD‑L1 in the periodontal tissues of the mice were analyzed using flow cytometry and immunohistochemistry. PD‑L1 was inducibly expressed on the PDLCs by the inflammatory cytokines and periodontal pathogens. The inflammation‑induced expression of PD‑L1 was shown to cause the apoptosis of activated T lymphocytes and improve the survival of PDLCs. Furthermore, in the mouse model of experimental periodontitis, the expression of PD‑L1 in severe cases of periodontitis was significantly lower, compared with that in mild cases. By contrast, no significant differences were observed between the healthy control and severe periodontitis groups. The results of the present study showed that the expression of PD‑L1 may inhibit the destruction of periodontal tissues, indicating the involvement of a possible protective feedback mechanism against periodontal infection.

Citing Articles

The role of programmed death receptor (PD-)1/PD-ligand (L)1 in periodontitis and cancer.

Groeger S, Meyle J Periodontol 2000. 2024; 96(1):150-169.

PMID: 38351432 PMC: 11579837. DOI: 10.1111/prd.12548.

25-hydroxyvitamin D generates immunomodulatory plasticity in human periodontal ligament-derived mesenchymal stromal cells that is inflammatory context-dependent.

Behm C, Blufstein A, Gahn J, Moritz A, Rausch-Fan X, Andrukhov O Front Immunol. 2023; 14:1100041.

PMID: 36761739 PMC: 9902380. DOI: 10.3389/fimmu.2023.1100041.

Mucosal circadian rhythm pathway genes altered by aging and periodontitis.

Ebersole J, Gonzalez O PLoS One. 2022; 17(12):e0275199.

PMID: 36472983 PMC: 9725147. DOI: 10.1371/journal.pone.0275199.

PD-L1, a Potential Immunomodulator Linking Immunology and Orthodontically Induced Inflammatory Root Resorption (OIIRR): Friend or Foe?.

Yong J, Groger S, von Bremen J, Meyle J, Ruf S Int J Mol Sci. 2022; 23(19).

PMID: 36232704 PMC: 9570182. DOI: 10.3390/ijms231911405.

Macrophages: A communication network linking infection and associated systemic diseases.

Lin J, Huang D, Xu H, Zhan F, Tan X Front Immunol. 2022; 13:952040.

PMID: 35967399 PMC: 9363567. DOI: 10.3389/fimmu.2022.952040.

References

Teng Y, Nguyen H, Gao X, Kong Y, Gorczynski R, Singh B . Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest. 2000; 106(6):R59-67. PMC: 3102542. DOI: 10.1172/jci10763. View

de Brito L, Teles F, Teles R, Totola A, Vieira L, Sobrinho A . T-lymphocyte and cytokine expression in human inflammatory periapical lesions. J Endod. 2012; 38(4):481-5. DOI: 10.1016/j.joen.2011.12.010. View

Fujita T, Shiba H, Sakata M, Uchida Y, Nakamura S, Kurihara H . SPARC stimulates the synthesis of OPG/OCIF, MMP-2 and DNA in human periodontal ligament cells. J Oral Pathol Med. 2002; 31(6):345-52. DOI: 10.1034/j.1600-0714.2002.00188.x. View

Fukushima H, Kajiya H, Takada K, Okamoto F, Okabe K . Expression and role of RANKL in periodontal ligament cells during physiological root-resorption in human deciduous teeth. Eur J Oral Sci. 2003; 111(4):346-52. DOI: 10.1034/j.1600-0722.2003.00051.x. View

Eke P, Dye B, Wei L, Thornton-Evans G, Genco R . Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012; 91(10):914-20. DOI: 10.1177/0022034512457373. View

Gemmell E, Seymour G . Modulation of immune responses to periodontal bacteria. Curr Opin Periodontol. 1994; :28-38. View

Arnold L, BARAM P . In vitro culture of periodontal ligament cells. J Dent Res. 1972; 51(4):953-9. DOI: 10.1177/00220345720510043801. View

Blank C, Kuball J, Voelkl S, Wiendl H, Becker B, Walter B . Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro. Int J Cancer. 2006; 119(2):317-27. DOI: 10.1002/ijc.21775. View

Dong H, Chen X . Immunoregulatory role of B7-H1 in chronicity of inflammatory responses. Cell Mol Immunol. 2006; 3(3):179-87. PMC: 2186063. View

10.

Lu W, Lu L, Feng Y, Chen J, Li Y, Kong X . Inflammation promotes oral squamous carcinoma immune evasion via induced programmed death ligand-1 surface expression. Oncol Lett. 2013; 5(5):1519-1526. PMC: 3678870. DOI: 10.3892/ol.2013.1238. View

11.

Graves D . The potential role of chemokines and inflammatory cytokines in periodontal disease progression. Clin Infect Dis. 1999; 28(3):482-90. DOI: 10.1086/515178. View

12.

Choi S, Cho T, Kwon S, Lee G, Cho J . Chondrogenesis of periodontal ligament stem cells by transforming growth factor-β3 and bone morphogenetic protein-6 in a normal healthy impacted third molar. Int J Oral Sci. 2013; 5(1):7-13. PMC: 3632767. DOI: 10.1038/ijos.2013.19. View

13.

Bascones-Martinez A, Munoz-Corcuera M, Noronha S, Mota P, Bascones-Ilundain C, Campo-Trapero J . Host defence mechanisms against bacterial aggression in periodontal disease: Basic mechanisms. Med Oral Patol Oral Cir Bucal. 2009; 14(12):e680-5. DOI: 10.4317/medoral.14.e680. View

14.

Dixon D, Bainbridge B, Darveau R . Modulation of the innate immune response within the periodontium. Periodontol 2000. 2004; 35:53-74. DOI: 10.1111/j.0906-6713.2004.003556.x. View

15.

Groeger S, Domann E, Gonzales J, Chakraborty T, Meyle J . B7-H1 and B7-DC receptors of oral squamous carcinoma cells are upregulated by Porphyromonas gingivalis. Immunobiology. 2011; 216(12):1302-10. DOI: 10.1016/j.imbio.2011.05.005. View

16.

Alexander M, Damoulis P . The role of cytokines in the pathogenesis of periodontal disease. Curr Opin Periodontol. 1994; :39-53. View

17.

Zitvogel L, Kroemer G . Targeting PD-1/PD-L1 interactions for cancer immunotherapy. Oncoimmunology. 2012; 1(8):1223-1225. PMC: 3518493. DOI: 10.4161/onci.21335. View

18.

Hashim J, RUBEN M, Kramer G . Cellular and immune mechanisms in juvenile periodontitis. J West Soc Periodontol Periodontal Abstr. 1979; 27(2):40-7. View

19.

Kilian M . [Role of the immune system in chronic periodontitis]. Tandlaegebladet. 1979; 83(4):123-7. View

20.

Chen J, Feng Y, Lu L, Wang H, Dai L, Li Y . Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway. Immunobiology. 2011; 217(4):385-93. DOI: 10.1016/j.imbio.2011.10.016. View